Restructure Information
In November 2025, the United States Bankruptcy Court for the Southern District of New York approved the Chapter 11 Plan of Reorganization for Purdue Pharma L.P. The Company is now focused on satisfying the conditions that must be met for the Plan to go effective – the date the new company, Knoa Pharma, will emerge from bankruptcy. The business continues uninterrupted. We are operating fully, honoring our existing relationships and meeting our obligations to our partners and customers.
Rhodes Pharmaceuticals L.P. has developed and distributed quality pharmaceutical products nationwide since 2008. With our R&D capabilities, industry partnerships, broad customer base, and strong relationships with suppliers, we offer reliable supply of high-quality products at competitive prices. Rhodes is a wholly-owned subsidiary of Purdue Pharma L.P.
Experience
Our management team has extensive experience in the pharmaceutical industry.
Expertise
Strong focus on product development of quality products highlighted by exceptional manufacturing and distribution strategies.
Products
Our goal is to provide unparalleled delivery of quality pharmaceutical products while continuing to build lasting relationships within the pharmaceutical community.